Results 181 to 190 of about 52,178 (281)

Advancing Cancer Immunotherapy: Chimeric Antigen Receptor (CAR)-T Cell Engineering through Novel Screening Methods. [PDF]

Biomol Ther (Seoul)
Ha J, Seong J.
europepmc   +1 more source

A novel SadP-scFv UCHT1 lectibody activates T cells and mediates lysis of Burkitt's lymphoma cells. [PDF]

RSC Chem Biol
Tomisch J, Gräber J, Makshakova ON, Salavei P, Rosato F, Mariscal SF, Varrot A, Imberty A, Römer W.   +8 more
europepmc   +1 more source

Construction of anti-HER2 affibody-directed CAR-NK and its synergistic effects with doxorubicin-loaded nanodrug against HER2-positive breast cancer. [PDF]

Front Immunol
He X, Liang Z, Liu Q, Zhang X, Liang H, Jia R, Sheng W.   +6 more
europepmc   +1 more source

Natural Killer Cells in Cancer Immunotherapy [PDF]

, 2019
Arndt MA, Chester C, Cortez VS, D'Andrea A, Elsasser D, Ferrini S, Gao Y, Hartmann F, Lotze MT, Miller JS, Orr MT, Seillet C, Soiffer RJ, Soto EO, Weiner LM, Yron I   +15 more
core   +1 more source

Development of production methodologies for scFv-Fc conjugated critical reagents to support CAR-T clinical programs. [PDF]

Bioanalysis
O'Connor E, Lachacz E, Delmar J, D'souza B, Edwards S, Griffin C, Lin R, Mody N, Salas A, Schoch-Lopez N, Shah M, Shih A, van Dyk D, Xu Y.   +13 more
europepmc   +1 more source

Phenotypic discovery and therapeutic evaluation of an <i>ITGA3B1</i>-targeting antibody-drug conjugate for bladder cancer. [PDF]

Sci Adv
Lee J, Jung H, Kim EG, Ahn J, Haffner MC, Nelson PS, Kim KP, Lee JK, Yi EC, Kim KM.   +9 more
europepmc   +1 more source

Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells

Targeted oncology, 2016
Jörg U. Schmohl, M. Gleason, M. Gleason, Phillip Dougherty, Jeffrey S. Miller, D. Vallera   +5 more
semanticscholar   +1 more source

Construction of a naive human phage scFv library and selection, identification of human scFvs

Frontiers in Immunology, 2013
Liu Jiajia, Gao Yan, Guo Xiyuan, Nian Siji, Yuan Qing   +4 more
openaire   +1 more source

Retraction Note: High efficient expression of a functional humanized single-chain variable fragment (scFv) antibody against CD22 in Pichia pastoris. [PDF]

Appl Microbiol Biotechnol
Zarei N, Vaziri B, Shokrgozar MA, Mahdian R, Fazel R, Khalaj V.   +5 more
europepmc   +1 more source

Strategies to Screen and Evaluate Brain Targeting Antibodies Using an iPSC-Derived Blood-Brain Barrier Model. [PDF]

Antibodies (Basel)
Choi ES, Sahota S, Burnham E, Ding Y, Shusta EV.   +4 more
europepmc   +1 more source